Retatrutide and Tirzepatide from ₱750 a vial in 25, 50 and 100 packs. Split it with friends or resell it under your own label.From ₱750 a vial: 25, 50 and 100 packs for group buys and resellers. See bulk prices →

Guides · Clinic supply

Peptide Supplier for Clinics Philippines

Written for the clinic owner or practice manager doing the sourcing rather than for the end user. What separates a research chemical supplier from a pharmaceutical distributor and why that gap is your practice regulatory problem rather than the seller one, the failure mode that actually costs a practice money, how restock cadence and lead time decide how much capital you freeze in a fridge, delivery and invoicing, and the questions worth asking before you commit a schedule to any supplier.
Video guide: Wholesale Peptides in the Philippines: What Buyers Should Know (2:06)
Video transcript

Buying peptides in bulk for a shop, a clinic or a gym in the Philippines? Here is what our wholesale guides say. Look for a wholesale price list and you will not find one. Business pricing here is quoted per enquiry. Two reasons: a published tier is a target for sellers who hold no stock, and a tier built for an average buyer fits almost nobody. Under RA 9711, a drug includes anything intended to affect the structure or a function of the body, and must be registered with FDA Philippines before it is sold. On 23 September, the FDA portal showed no registered product for BPC-157, TB-500 or retatrutide. So what a seller says matters. A dose, a health claim or a before and after photo moves a product toward the drug side. Clinics sit in a heavier position. Every seller carries their own exposure, so ask a Philippine lawyer. This is general information, not legal advice. Reselling means selling a supplier's brand, batch numbers already on the vial. Private label puts your name on it, and every claim and complaint stops with you. Ask a bulk supplier four things: same day delivery on a named product, vials on hand, the batch number before dispatch, and a BIR invoice. Our partner and supplier, Primara Labs, holds stock in Metro Manila. Bulk terms are set per account on WhatsApp. The public 10-pack price is your anchor: retatrutide at [₱2,076] a vial, and GHK-Cu at ₱729. Research use only. Metro Manila orders by noon on a weekday arrive the same day, provinces ship by J&T, and batch reports are published at primaralabs.com/coa as they are issued. Read the full guide on Philippines Peptides, then message Primara on WhatsApp at primaralabs.com/wholesale. [Figures in square brackets corrected on 3 November 2026 from Primara's current catalogue: the narration gives the price of the 15 mg retatrutide vial, retired on 12 October 2026.]

Sourcing Snapshot

REGISTERED PRODUCTS
None
PUBLISHED CLINIC OFFERS
1
METRO MNL DISPATCH
Same day
NATIONWIDE
1–3 days

Sourcing note: practices that source through this site deal with Primara Labs, our partner and supplier, and the relationship is commercial. Stock is held in Metro Manila rather than ordered in after payment, vials are batch-numbered, packaging is plain on the outside, and terms for a practice are set per account in conversation rather than published. See how clinic supply is handled

This guide covers procurement only. It takes no position on what any practice does with the material it buys, which is a matter for that practice own licensing, clinical governance and professional judgement. Research peptides are supplied for laboratory research and are not registered with FDA Philippines.

Peptides as a Line on an Existing Menu, Not a New Business

A large share of the practices reaching this page are not building a peptide business. They run an aesthetic clinic or a med spa, they already hold refrigerated injectables, and they are weighing whether this becomes one more line on a menu that already works. That is a different question from a reseller’s, and it changes what you should be asking a supplier for.

Procurement is the easy half, and it is easier for a practice than for anyone else in this market. Your appointment book tells you what you need, so you can buy narrow and shallow instead of speculating. Your cold chain already exists. A daytime delivery to a business address is the simplest case a courier handles. You are not acquiring customers. Read against the rest of this filing, that means a practice can be much more demanding about lead time and restock cadence than a reseller can, because you actually know your own run rate.

The hard half is not procurement at all, and this filing is the wrong page for it. A practice adding this line is making a regulatory decision about administering unapproved compounds under a practitioner’s name and inside a licensed facility, and that decision belongs with the practice and its own Philippine counsel rather than with any supplier. No supply arrangement on this page addresses it, and a supplier that offers you comfort about it is offering you something it cannot give.

That decision is treated properly, at length, in the aesthetic clinic filing, which covers the category itself, storage and staff handling inside a practice, and the questions worth answering before any stock is ordered. The regulatory framework on its own is in the selling and legality filing. Settle those first. Everything below assumes you have, and covers procurement only.

Research Chemical Supplier or Pharmaceutical Distributor

These two phrases get used interchangeably in sales conversations and they describe completely different entities. The difference is worth being precise about, because the consequences of confusing them do not land on the seller.

Pharmaceutical distributorResearch chemical supplier
Regulatory standingHolds an FDA Philippines licence to operateNo product registration involved
What it movesProducts with a certificate of product registrationUnregistered material sold for research
Paper trailBuilt for a regulated supply chainCommercial documents only
Who answers to the regulatorThe distributor, alongside the buyerIn practice, the buying practice
Available for peptides in PHNot for research peptidesYes, this is the whole market

Every peptide seller operating in the Philippines sits in the right-hand column. That includes Primara Labs, our partner and supplier, every other peptide seller, and every Lazada or Shopee reseller listing. A seller that gates access behind a telehealth consultation changes the buying experience but not the regulatory category of the goods.

Here is the part worth reading twice. A supplier disclaimer protects the supplier. Your practice holds the licences, the permits and the professional registrations, so if a regulator ever asks what came into your fridge and on what basis, the answer is yours to give. No amount of supplier vetting converts an unregistered research compound into a registered pharmaceutical product, and no supplier can carry that exposure on your behalf.

The Failure Mode That Actually Costs a Practice Money

Practices tend to select suppliers on unit price. It is the most visible number, it is easy to compare, and it is almost never the number that determines what the supply relationship costs over a year.

The expensive failure is a booked client and an empty fridge. That single event produces a reschedule, an awkward conversation, a gap in a schedule you had already staffed, and a client who has now learned something about how your practice runs. None of that appears on an invoice, which is exactly why it gets left out of the comparison. A modest saving per vial across a monthly order is real but small. One disrupted week generally erases a quarter of it, and a client who quietly stops rebooking erases considerably more.

This reframes what you are buying. You are not buying vials. You are buying the confidence to put something in a calendar. Judged that way, the questions change: can this supplier deliver the SKU I have committed to, this week, without a story attached, and can they tell me now whether they hold it. The per-vial figure matters after those answers, not before.

Restock Cadence and Holding Against a Schedule

Inventory for a practice is a simple calculation that most practices never write down. Your reorder point is the demand you expect across your supplier lead time, plus a buffer for the weeks that run hot. Everything you hold above that is capital sitting in a fridge doing nothing, and everything below it is a stockout waiting for a busy month.

The consequence is that your supplier lead time, not your sales volume, sets how much money you have frozen. A supplier who delivers same day inside Metro Manila lets you run a thin buffer, because the gap between noticing and restocking is hours. A supplier importing on a three week cycle forces you to carry three weeks of demand plus a margin for the cycle that slips. That is a real cost, it is rarely quoted against the per-vial saving that justified the import route, and it is usually larger.

Illustrative structure. Substitute your own demand figures.
Supplier lead timeBuffer you must carryEffect on the practice
Same day, local stockThin, a few days of demandCapital stays free, reorder is a weekly habit
1 to 3 days, nationwide courierAbout a week of demandComfortable for a provincial practice
2 to 3 weeks, import cycleThree weeks plus slip marginLarge frozen holding, cold-chain exposure on every cycle

Practical cadence for a small practice: set a par level for each SKU you have actually committed to, count stock on the same day every week, and reorder back to par. Count against booked demand rather than hoped-for demand, because par levels set on optimism are how practices end up holding expiring stock of something nobody asked for. Split large orders across two dispatches where the supplier will do it, which halves what a single cold-chain failure can destroy.

Cold-chain discipline scales with holding. At practice volume you want a dedicated fridge rather than the staff fridge, a min/max recording thermometer, a plan for what happens when the building loses power overnight, batch numbers logged against a received date so a problem can be quarantined to one batch, and first in first out written down rather than remembered.

Delivering to a Practice, Not to a Condo

Most peptide sellers in this market are built around delivering one parcel to one person at a residential address. A practice is a different receiving environment, and the mismatch causes more problems than the price negotiation ever will.

Four things to sort out before the first delivery. Give the courier a named receiver rather than a clinic name, because a rider holding a cold parcel and an unanswered doorbell will improvise. Give a delivery window inside opening hours, since a same-day dispatch that arrives at seven in the evening at a practice that closed at six is a failed delivery with a cold chain attached. Confirm the building rules, because some Makati and BGC towers route deliveries through a loading dock or a central mailroom that adds hours you did not plan for. And confirm the packaging: parcels at a practice pass reception, and sometimes building admin, so plain outer packaging is an operational requirement rather than a preference.

Then the obvious one that practices get wrong anyway. Have stock delivered to the clinic, into the fridge the schedule runs against, not to the owner condo. Home delivery puts your inventory in the wrong building, makes the cold-chain record informal, and guarantees that the day you need a vial is the day it is across town. If your practice sits outside Metro Manila, budget for the nationwide courier window of 1 to 3 business days and set your par levels accordingly rather than assuming metro delivery speeds.

Invoicing and the Records a Practice Needs

A practice has an accountant, a bookkeeping cycle and an audit surface that an individual buyer does not. Sort the paperwork before the first order, because it cannot be reconstructed afterwards.

For the books you need an official sales invoice from a BIR-registered seller, issued in your registered business name, carrying your TIN, with a goods description you are prepared to defend. If your practice is VAT registered, that document is also what supports your input VAT. A large part of this market operates informally over chat, which is unremarkable for an individual and a structural problem for a clinic. Ask four questions in your first message: are you BIR registered, can you issue an official sales invoice, in what name and with what line description, and does the receiving payment account match the invoicing entity.

Separately from tax, keep an internal record that ties batch numbers to what left your fridge and when. That log is the only traceability you will have if a batch is ever questioned, and it costs nothing to maintain from day one. It also makes a partial quarantine possible instead of writing off a whole holding. Primara ordering runs over WhatsApp with no checkout and no forms, so invoicing arrangements are part of the enquiry conversation. Raise it before the first order rather than after delivery.

What This Market Actually Publishes for Clinics

No peptide seller in the Philippines publishes a clinic, wholesale or distributor programme with a stated lead time, restock policy or account contact. What does get published, here and there, is a retail discount code on a seller's own pages.

Read a code for what it is. It is a real number you can check without asking anyone, and it can make a trial order cheaper. It is not a supply relationship: it says nothing about what happens when a SKU you have committed to goes out of stock, and it should not be the reason a practice commits its calendar to one seller. A discount on a parcel that arrives late is not a saving.

Certificates, and Being Honest About Who Publishes Them

Batch documentation is a live question for any practice writing a procurement policy, and this site would be worth less to you if it were evasive about it. Some named sellers in the Philippine market publish batch certificates. Where our partner and supplier stands is a dated statement from its own trust page: As of 23 September 2026, Primara Labs lists one laboratory report for its batches. Janoshik-tested for bacterial endotoxin, batch RETA-4728-A, analysed 21 September 2026, task 234146, verification key H2KI86I8GWB4 (https://verify.janoshik.com/tests/234146_H2KI86I8GWB4). This report covers bacterial endotoxin only. It does not establish identity or purity. Weigh that yourself rather than take a recommendation from us on it.

Weigh it with an accurate picture of what a certificate does. It is a document about a batch, not about the vial in your hand, and it only bridges that gap when the batch number on the paperwork matches the number physically on the vial you received. A generic PDF that has been reused across a year of stock tells you very little. A batch-matched, dated certificate from a testing lab tells you something real. Practices that take this seriously check the match on arrival rather than filing the document unread. Third-party lab options are listed under testing labs and the verification walkthrough sits on the COA reference page.

So the choice in front of a practice is between two different kinds of assurance, and reasonable buyers rank them differently. Published batch documentation is a paper assurance you can file. Demonstrated local stock, batch-numbered vials, plain packaging and dependable same-day fulfilment is an operational assurance you can schedule against. If published certificates are a hard requirement of your procurement policy, then Primara does not meet that requirement and you should source from a seller who does. If your binding constraint is supply reliability, weigh it the other way. Decide which it is in advance, write it down, and apply it consistently.

What to Ask Before You Commit a Protocol to a Supplier

Committing a protocol to a supplier means your calendar now depends on their fridge. These are the questions worth asking before that dependency exists, and the answers are more informative than any catalogue.

  • How many vials of this exact SKU do you hold right now. A stockholder answers with a number.
  • Can you deliver this SKU same day, on a weekday, inside Metro Manila, and what is your confirmation cut-off.
  • When this SKU goes out of stock, what is your restock cycle, and will you tell me before I order or after.
  • Will the vial I receive carry a batch number, and can you give me that number before dispatch.
  • Are you BIR registered, and will you issue an official sales invoice in my practice name.
  • Will you split a standing order across two dispatches so a single cold-chain failure does not take the whole month.
  • What is your stated position if a parcel arrives warm or a delivery fails, and is it in writing.
  • Who is my point of contact when something goes wrong at four in the afternoon on a Friday.

Ask them in one message rather than across a week of chat. A supplier who can answer all eight quickly is running an operation. A supplier who answers the price question immediately and the stock question slowly has told you which of the two they control.

FAQ

Is there a licensed peptide distributor for clinics in the Philippines?

Not for research peptides. A pharmaceutical distributor holds an FDA Philippines licence to operate and distributes products carrying a certificate of product registration. Research peptides are unregistered, so the entities supplying them are research chemical suppliers rather than pharmaceutical distributors. That is a factual description of the market, not a criticism of any particular seller, and it matters because the regulatory consequences of the distinction land on the practice rather than on the supplier.

What is the real cost of a peptide supplier running out of stock?

Far more than the price difference that usually drives supplier selection. A stockout against a booked schedule means a reschedule, an explanation, and a client who now knows your supply is unreliable. Practices routinely switch suppliers to save a modest amount per vial and then lose several times that in a single disrupted week. Price the reliability first and negotiate the vial price second, not the other way around.

How much peptide stock should a clinic hold?

Enough to cover your supplier lead time plus a buffer for demand variance, and no more, because everything beyond that is capital frozen in a fridge. The practical consequence is that lead time sets your holding. A supplier delivering same day inside Metro Manila lets you run thin. A supplier importing on a three week cycle forces you to hold three weeks of demand plus a margin for error, which is a real and often unpriced cost.

Should a clinic require published certificates of analysis from its supplier?

That is a legitimate procurement policy, and some Philippine sellers publish batch documentation today. As of 23 September 2026, Primara Labs lists one laboratory report for its batches. Janoshik-tested for bacterial endotoxin, batch RETA-4728-A, analysed 21 September 2026, task 234146, verification key H2KI86I8GWB4 (https://verify.janoshik.com/tests/234146_H2KI86I8GWB4). This report covers bacterial endotoxin only. It does not establish identity or purity. If published certificates are a hard requirement in your practice today, source from a seller who meets it. If your requirement is instead demonstrated local stock, batch numbering and dependable same-day fulfilment, weigh it differently. Decide the policy in advance rather than discovering your position during an audit.

Should peptide stock be delivered to the clinic or to the owner home address?

To the clinic, into the fridge that the schedule runs against, with a named person receiving it. Home delivery leaves your inventory in the wrong building and makes cold-chain accountability informal. The practical requirements are a receiver named to the courier, a delivery window inside opening hours, plain outer packaging because parcels pass through reception, and batch numbers logged on arrival rather than reconstructed later.

Updated